186 related articles for article (PubMed ID: 35191812)
1. Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3.
Zhang M; Chen Y; Chen H; Shen Y; Pang L; Wu W; Yu Z
Bioengineered; 2022 Feb; 13(2):4260-4270. PubMed ID: 35191812
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
Deng H; Yu B; Li Y
Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
Ren ZH; Tong YH; Xu W; Ma J; Chen Y
Phytomedicine; 2010 Mar; 17(3-4):212-8. PubMed ID: 19800776
[TBL] [Abstract][Full Text] [Related]
6. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J
Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.
Weng YS; Wang HF; Pai PY; Jong GP; Lai CH; Chung LC; Hsieh DJ; HsuanDay C; Kuo WW; Huang CY
Am J Chin Med; 2015; 43(8):1567-91. PubMed ID: 26621443
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress.
Li Y; Fu Y; Sun J; Shen J; Liu F; Ning B; Lu Z; Wei L; Jiang X
J Ethnopharmacol; 2022 Jan; 282():114595. PubMed ID: 34517060
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA from Salvia miltiorrhiza exerts anti-fibrotic effects on cardiac fibroblasts and rat heart tissues by suppressing the levels of pro-fibrotic factors: The key role of miR-618.
Yan N; Xiao C; Wang X; Xu Z; Yang J
J Food Biochem; 2022 Feb; 46(2):e14078. PubMed ID: 35014054
[TBL] [Abstract][Full Text] [Related]
11. Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization.
Fan G; Zhu Y; Guo H; Wang X; Wang H; Gao X
J Cardiovasc Pharmacol; 2011 Mar; 57(3):340-7. PubMed ID: 21383591
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.
Tong Y; Xu W; Han H; Chen Y; Yang J; Qiao H; Hong D; Wu Y; Zhou C
Phytomedicine; 2011 Apr; 18(6):443-50. PubMed ID: 21146968
[TBL] [Abstract][Full Text] [Related]
13. Specific Degradation of Endogenous Tau Protein and Inhibition of Tau Fibrillation by Tanshinone IIA through the Ubiquitin-Proteasome Pathway.
Cai N; Chen J; Bi D; Gu L; Yao L; Li X; Li H; Xu H; Hu Z; Liu Q; Xu X
J Agric Food Chem; 2020 Feb; 68(7):2054-2062. PubMed ID: 31995984
[TBL] [Abstract][Full Text] [Related]
14. Anti-Obesity Effects of Tanshinone I from
Jung DY; Kim JH; Jung MH
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32349456
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic Extract and Tanshinone IIA Derived from
Zhang XW; Zhou M; An L; Zhang P; Li P; Chen J
Am J Chin Med; 2020; 48(6):1455-1473. PubMed ID: 32933312
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA attenuates cerebral aneurysm formation by inhibiting the NF‑κB‑mediated inflammatory response.
Ma J; Hou D; Wei Z; Zhu J; Lu H; Li Z; Wang X; Li Y; Qiao G; Liu N
Mol Med Rep; 2019 Aug; 20(2):1621-1628. PubMed ID: 31257487
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.
Ding B; Lin C; Liu Q; He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Yang W
J Neuroinflammation; 2020 Oct; 17(1):302. PubMed ID: 33054814
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
Wang P; Wu X; Bao Y; Fang J; Zhou S; Gao J; Pi R; Mou YG; Liu P
Pharmazie; 2011 Jul; 66(7):517-24. PubMed ID: 21812327
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA regulates expression of glucose transporter 1 via activation of the HIF‑1α signaling pathway.
Zhou Y; Zhang H; Huang Y; Wu S; Liu Z
Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36069225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
